MCM
OMCL icon

Marathon Capital Management’s Omnicell OMCL Stock Holding History

Marathon Capital Management’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,223
Closed -$330K – 207
2021
Q3 		$330K Buy
2,223
+235
+12% +$36K 0.07% 144
2021
Q2 		$301K Sell
1,988
-312
-14% -$43.4K 0.07% 132
2021
Q1 		$298K Buy
+2,300
New +$295K 0.08% 126

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marathon Capital Management's OMCL Position: Q4 2021 in Review

Marathon Capital Management sold out of Omnicell (OMCL) in Q4 2021, closing a stake of 2,223 shares — an estimated $330K sold.

Marathon Capital Management first reported a position in OMCL in Q1 2021 and held it in 3 quarters. The position peaked at $330K in Q3 2021. 422 funds tracked by Wall St. Rank hold OMCL as of Q4 2021.

  • Marathon Capital Management reported no remaining Omnicell position as of Q4 2021 after selling out during the quarter.
  • Marathon Capital Management sold 2,223 Omnicell shares in Q4 2021, an estimated $330K.
  • Marathon Capital Management first reported a position in Omnicell in Q1 2021 and held it in 3 quarters.
  • Marathon Capital Management's Omnicell position peaked at $330K in Q3 2021.
  • 422 funds tracked by Wall St. Rank held Omnicell as of Q4 2021.

Based on Marathon Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.